A Malaysia 97 monovalent foot-and-mouth disease vaccine (> 6PD(50)/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination

Loading...
Thumbnail Image

Authors

Singanallur, Balasubramanian Nagendrakumar
Nguyen, Thi Thu Hong
Fosgate, Geoffrey Theodore
Morris, Michelle Jacqueline
Davis, Andrew J.
Giles, Michelle
Kim, Van Phuc
Quach, Vo Ngon
Le, Thi Thu Phuong
Nguyen, Ngoc Hong Phuc

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Pigs play a significant role during outbreaks of foot-and-mouth disease (FMD) due to their ability to amplify the virus. It is therefore essential to determine what role vaccination could play to prevent clinical disease and lower virus excretion into the environment. In this study we investigated the efficacy of the double oil emulsion A Malaysia 97 vaccine (>6PD50/dose) against heterologous challenge with an isolate belonging to the A SEA-97 lineage at 4 and 7 days post vaccination (dpv). In addition, we determined whether physical separation of pigs in the same room could prevent virus transmission. Statistically there was no difference in the level of protection offered by 4 and 7 dpv. However, no clinical disease or viral RNA was detected in the blood of pigs challenged 4 dpv, although three of the pigs had antibodies to the non-structural proteins (NSPs), indicating viral replication. Viral RNA was also detected in nasal and saliva swabs, but on very few occasions. Two of the pigs vaccinated seven days prior to challenge had vesicles distal from the injection site, but on the inoculated foot, and two pigs had viral RNA detected in the blood. One pig sero-converted to the NSPs. In contrast, all unvaccinated and inoculated pigs had evidenceof infection. No infection occurred in any of the susceptible pigs in the same room, but separated from the infected pigs, indicating that strict biosecurity measures were sufficient under these experimental conditions to prevent virus transmission. However, viral RNA was detected in the nasal swabs of one group of pigs, but apparently not at sufficient levels to cause clinical disease. Vaccination led to a significant decrease in viral RNA in vaccinated pigs compared to unvaccinated and infected pigs, even with this heterologous challenge, and could therefore be considered as a control option during outbreaks.

Description

Keywords

Serotype A, Pigs, Vaccination, Early protection, Heterologous challenge, Foot-and-mouth disease, FMD

Sustainable Development Goals

Citation

Singanallur, BN, Nguyen, TTH, Fosgate, TG, Morris, MJ, Davis, A, Giles, M, Kim,VP, Quach, VN, Le, TTP, Nguyen, NHP, Tran, XH, Vo, VH, Le, TQ, Tran, MT, Ngo, TL & Vosloo, W 2015, 'A Malaysia 97 monovalent foot-and-mouth disease vaccine (> 6PD(50)/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination', Vaccine, vol. 33, pp. 4513-4519.